Search Results - "Camp, E Ramsay"

Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma by Esnaola, Nestor F., Meyer, Joshua E., Karachristos, Andreas, Maranki, Jennifer L., Camp, E. Ramsay, Denlinger, Crystal S.

“…Cholangiocarcinomas are rare biliary tract tumors that are often challenging to diagnose and treat. Cholangiocarcinomas are generally categorized as…”
Get full text

miR-145 Antagonizes SNAI1-Mediated Stemness and Radiation Resistance in Colorectal Cancer by Zhu, Yun, Wang, Cindy, Becker, Scott A., Hurst, Katie, Nogueira, Lourdes M., Findlay, Victoria J., Camp, E. Ramsay

“…Epithelial-to-mesenchymal transition (EMT) has been closely linked with therapy resistance and cancer stem cells (CSCs). However, EMT pathways have proven…”
Get full text

The clinical implications of immunogenomics in colorectal cancer: A path for precision medicine by Riley, Jenny M., Cross, Ashley W., Paulos, Chrystal M., Rubinstein, Mark P., Wrangle, John, Camp, E. Ramsay

“…Colorectal cancer (CRC) remains the third most common malignancy and the second‐leading cause of cancer‐related deaths in the United States. Large multi‐omic…”
Get full text

Chronic Oxaliplatin Resistance Induces Epithelial-to-Mesenchymal Transition in Colorectal Cancer Cell Lines by YANG, Anthony D, FAN FAN, RAMSAY CAMP, E, VAN BUREN, George, WENBIAO LIU, SOMCIO, Ray, GRAY, Michael J, HAIYUN CHENG, HOFF, Paulo M, ELLIS, Lee M

“…Purpose: Epithelial-to-mesenchymal transition (EMT) is a process whereby cells acquire molecular alterations that facilitate cell motility and invasion. In…”
Get full text

Merkel cell carcinoma: Identification of prognostic factors unique to tumors located in the head and neck based on analysis of SEER data by Smith, Valerie A., Camp, E. Ramsay, Lentsch, Eric J.

“…Objectives/Hypothesis: Merkel cell carcinoma (MCC) is an aggressive cutaneous neoplasm that occurs most frequently in the head and neck region. Because of its…”
Get full text

Therapeutic implications of bioactive sphingolipids: A focus on colorectal cancer by Camp, E. Ramsay, Patterson, Logan D., Kester, Mark, Voelkel-Johnson, Christina

“…Therapy of colorectal cancer (CRC), especially a subset known as locally advanced rectal cancer, is challenged by progression and recurrence. Sphingolipids, a…”
Get full text

Synchronous Upper Intestinal Neurofibromas and Duodenal Periampullary Well-Differentiated Neuroendocrine Tumor Associated With Neurofibromatosis 1 by Balmer, Jacob C, Mikhaylov, Yana, Lewin, David N, Mahvi, David M, Ramsay Camp, E

“…Neurofibromatosis type I (NF1) is an autosomal dominant genetic disorder associated with characteristic skin findings, as well as a fourfold increase in risk…”
Get more information

Patient‐ and system‐level factors associated with racial/ethnic disparities in the delivery of guideline‐concordant therapy among US patients with gastric cancer by Costa, Wilson L., Tan, Mimi C., Camp, E. Ramsay, Thrift, Aaron P.

“…Background Disparities in gastric cancer (GC) outcomes show a higher disease burden among minorities. We aimed to evaluate the associations between…”
Get full text

Factors associated with inability to return to intended oncologic treatment in pancreatic cancer by Mickel, T. Alston, Kutlu, Onur C., Silberfein, Eric J., Hsu, Cary, Chai, Christy Y., Fisher, William E., Van Buren, George, Camp, E. Ramsay

“…Return to Intended Oncologic Treatment (RIOT) has been proposed as a quality metric in the care of cancer patients. We sought to define factors associated with…”
Get full text

Translational and oncologic significance of tertiary lymphoid structures in pancreatic adenocarcinoma by Gao, Zachary, Azar, Joseph, Zhu, Huili, Williams-Perez, Sophia, Kang, Sung Wook, Marginean, Celia, Rubinstein, Mark P, Makawita, Shalini, Lee, Hyun-Sung, Camp, E Ramsay

“…Pancreatic adenocarcinoma (PDAC) is an aggressive tumor with poor survival and limited treatment options. PDAC resistance to immunotherapeutic strategies is…”
Get full text

Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells by YANG, Anthony D, RAMSAY CAMP, E, ELLIS, Lee M, FAN FAN, LANLAN SHEN, GRAY, Michael J, WENBIAO LIU, SOMCIO, Ray, BAUER, Todd W, YAN WU, HICKLIN, Daniel J

“…Our laboratory has shown that vascular endothelial growth factor receptor-1 (VEGFR-1) expression on human pancreatic cancer cell lines mediates cell migration…”
Get full text

Application of an Advanced Image-Based Virtual Monoenergetic Reconstruction of Dual Source Dual-Energy CT Data at Low keV Increases Image Quality for Routine Pancreas Imaging by Hardie, Andrew D, Picard, Melissa M, Camp, E Ramsay, Perry, Jonathan D, Suranyi, Pal, De Cecco, Carlo N, Schoepf, U Joseph, Wichmann, Julian L

“…To compare image quality on contrast-enhanced dual-energy computed tomography (DECT) during the pancreatic parenchymal phase of pancreatic masses between…”
Get full text

SNAI2 modulates colorectal cancer 5-fluorouracil sensitivity through miR145 repression by Findlay, Victoria J, Wang, Cindy, Nogueira, Lourdes M, Hurst, Katie, Quirk, Daniel, Ethier, Stephen P, Staveley O'Carroll, Kevin F, Watson, Dennis K, Camp, E Ramsay

“…Epithelial-to-mesenchymal transition (EMT) has been associated with poor treatment outcomes in various malignancies and is inversely associated with miRNA145…”
Get full text

The impact of lymph node disease in extremity soft-tissue sarcomas: a population-based analysis by Johannesmeyer, David, M.D, Smith, Valerie, M.D, Cole, David J., M.D, Esnaola, Nestor F., M.D., M.Ph., M.B.A, Camp, E. Ramsay, M.D., M.S.C.R

“…Abstract Background Because of the low incidence of regional lymph node metastasis, node-positive soft-tissue sarcoma patients remain poorly characterized. Our…”
Get full text

Pre-treatment inflamed tumor immune microenvironment is associated with FOLFIRINOX response in pancreatic cancer by Gao, Zachary, Kang, Sung Wook, Erstad, Derek, Azar, Joseph, Van Buren, George, Fisher, William, Sun, Zequn, Rubinstein, Mark P, Lee, Hyun-Sung, Camp, E Ramsay

“…Pancreatic adenocarcinoma (PDAC) is an aggressive tumor with limited response to both chemotherapy and immunotherapy. Pre-treatment tumor features within the…”
Get full text

Differential immune signatures in the tumor microenvironment are associated with colon cancer racial disparities by Curran, Thomas, Sun, Zequn, Gerry, Brielle, Findlay, Victoria J., Wallace, Kristin, Li, Zihai, Paulos, Chrystal, Ford, Marvella, Rubinstein, Mark P., Chung, Dongjun, Camp, E. Ramsay

“…Background Disparities in colon cancer (CC) outcomes may be due to a more aggressive phenotype in African American patients in the setting of a decreased tumor…”
Get full text

The role of sentinel lymph node biopsy in select sarcoma patients: a meta-analysis by Wright, Sharee, M.D, Armeson, Kent, M.S, Hill, Elizabeth G., Ph.D, Streck, Christian, M.D, Leddy, Lee, M.D, Cole, David, M.D, Esnaola, Nestor, M.D., M.Ph., M.B.A, Camp, E. Ramsay, M.D., M.S.C.R

“…Abstract Background Sentinel lymph node (SLN) biopsy is a staging technique for occult lymph node disease. SLN biopsy has been applied to select patients with…”
Get full text

MicroRNA-510 promotes cell and tumor growth by targeting peroxiredoxin1 in breast cancer by Guo, Qi J, Mills, Jamie N, Bandurraga, Savannah G, Nogueira, Lourdes M, Mason, Natalie J, Camp, E Ramsay, Larue, Amanda C, Turner, David P, Findlay, Victoria J

“…MicroRNAs are small non-coding RNAs that are involved in the post-transcriptional negative regulation of mRNAs. MicroRNA 510 (miR-510) was initially shown to…”
Get full text

Molecular Mechanisms of Resistance to Therapies Targeting the Epidermal Growth Factor Receptor by Camp, E Ramsay, Summy, Justin, Bauer, Todd W, Liu, Wenbiao, Gallick, Gary E, Ellis, Lee M

“…Targeted therapies that inhibit the activity of tyrosine kinase receptors such as the epidermal growth factor receptor (EGFR) have shown activity against solid…”
Get full text

Phase 2 Trial of Induction Gemcitabine, Oxaliplatin, and Cetuximab Followed by Selective Capecitabine-Based Chemoradiation in Patients With Borderline Resectable or Unresectable Locally Advanced Pancreatic Cancer by Esnaola, Nestor F., MD, Chaudhary, Uzair B., MD, O'Brien, Paul, MD, Garrett-Mayer, Elizabeth, PhD, Camp, E. Ramsay, MD, Thomas, Melanie B., MD, Cole, David J., MD, Montero, Alberto J., MD, Hoffman, Brenda J., MD, Romagnuolo, Joseph, MD, Orwat, Kelly P., MD, Marshall, David T., MD

“…Purpose To evaluate, in a phase 2 study, the safety and efficacy of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based…”
Get full text